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Abstract
Our efforts to express in bacteria the enzymatically active reverse transcriptase (RT) of mouse mammary tumor virus (MMTV) have
shown that the RT is active only after adding 27 amino acid residues, which are derived from the end of the pro gene, to the amino-terminus
of the RT (Biochem, J. (1998) 329, 579–587). In the present study we have tested whether the mature RT found in virions is also fused
to protease-derived sequences. To this end, we have analyzed the RT molecules in virions of MMTV by using two antisera directed against
peptides, derived from either the carboxyl-terminus of MMTV protease or the middle of MMTV RT. The data suggest that the mature RT,
located in virions, contains at its amino-terminus sequences from the carboxyl-terminus of the protease protein. This finding supports
previous suggestions that MMTV RT is a transframe protein (derived from both pro and pol reading frames of MMTV) and that amino acid
residues located at the carboxyl-terminus of the protease have a dual usage as integral parts of both the protease and the RT enzymes.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Full-length transcripts of the integrated provirus serve as
the messenger RNA (mRNA) for the synthesis of the Gag,
Gag-Pro, and Gag-Pro-Pol polyprotein precursors of retro-
viruses (Coffin, 1996; Coffin et al., 1997). The translation of
the proteins encoded by the pro-pol genes is performed after
bypassing the termination codon at 3-end of the gag-read-
ing frame. The mechanism used in most retroviruses in-
volves a ribosomal slippage backward by one nucleotide (a
1 frameshift toward the 5-end) during mRNA translation.
Thus, the ribosomes move from the gag reading frame into
the pro-reading frame. In many retroviruses, including
mouse mammary tumor virus (MMTV), the pro gene lies in
a separate reading frame, which is distinct from both gag
and pol reading frames. Consequently, in these retroviruses
there is also a second 1 frameshift event to overcome the
second stop codon (located at the 3-end of the pro gene),
generating a full-length Gag-Pro-Pol precursor polyprotein
(Coffin et al., 1997; Hatfield et al., 1992). The precursor
polyproteins are all cleaved by the viral protease to the
final-sized protein products, including the viral reverse tran-
scriptase (RT).
MMTV was the first mammalian retrovirus identified
and is the only infectious retrovirus with a distinct type B
morphology, which was isolated as both endogenous and
exogenous viruses (Moore et al., 1979; Ringold, 1983).
Type B and type D retroviruses are the only retroviruses
shown to accumulate in their virions the p30 protein, which
possesses a dUTPase activity (Coffin et al., 1997; Hizi et al.,
1997; Bergman et al., 1994; Koppe et al., 1994). This
protein is unique in being a transframe protein, namely a
protein containing sequences derived from two separate
genomic translation reading frames. The amino-terminus of
MMTV p30 has 94 residues translated from the gag-reading
frame, which is also the precise sequence of the Gag nu-
cleocapsid (NC) protein and the rest of the protein is en-
coded by the pro reading frame (Hizi et al., 1997). Thus, in
these retroviruses there is a dual usage of gene regions for
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the translation of two independent and functionally different
proteins (p30 and NC) with long overlapping polypeptide
sequences. The viral protease is encoded by the rest of the
pro gene that terminates at a stop codon (Hizi et al., 1997;
Menendez-Arias et al., 1992).
The RT of MMTV is encoded by the pol gene open
reading frame, which is distinct from both the gag and the
pro reading frames (Moore et al., 1987). Our efforts to
express in bacteria an enzymatically active recombinant
MMTV RT have raised the possibility that this protein is
also a transframe protein. A fully active recombinant RT
could be obtained only after adding 27 non-pol-derived
amino acid residues to the amino-terminus of the RT (Taube
et al., 1998). These residues are encoded by the 3-end of
the pro gene and are present in the carboxyl-terminus of the
MMTV protease (Moore et al., 1987; Hizi et al., 1997; Jacks
et al., 1987). Based on the recombinant expression of
MMTV RT, the length of the protease-derived sequences,
necessary to restore the full enzymatic RT activity, ranges
between 10 and 27 residues. Yet, this evidence is indirect.
Moreover, one cannot rule out the possibility that in the
specific case of MMTV RT, the protease-derived sequences
are essential for the proper folding, solubility, and/or sta-
bility of only the bacterially expressed recombinant protein
(and the mature RT in virions does not need to contain this
extra sequence). Nevertheless, this argument is not sup-
ported by studies done with a variety of other recombinant
retroviral RTs. So far, all recombinant RTs expressed in
bacteria were fully active without any protease-derived se-
quences fused to their amino-termini. These include the RTs
of HIV-1,2 HIV-2, EIAV, MLV, FIV, PERV, and HTLV-1
(Hizi et al., 1991, 1998; Hizi and Hughes, 1988; Shahara-
bany et al., 1993; North et al., 1994; Owen et al., 1998;
Avidan et al., 2003). In two other instances, of the expres-
sion of BLV RT and second method for the expression of
HTLV-1 RT, the recombinant proteins were indeed trans-
frame, since they include sequences from the pro gene.
Nonetheless, these recombinant RTs do not include se-
quences that overlap the protease protein sequences, since in
these retroviruses the pro reading frame ends at a stop
codon, which is located at a significant distance downstream
to the carboxyl-terminus of the proteases (Perach and Hizi,
1999; Trentin et al., 1998).
In the present study, we have investigated directly the
origin of the amino-terminus of MMTV RT by analyzing
the mature protein molecules in virions of MMTV. By using
two anti-peptide-specific antisera, we have tested whether
the amino-terminus of the viral RT contains protease-de-
rived sequences. The data show that antibodies against the
carboxyl-terminal segment of MMTV protease recognize
the same RT molecules as those detected by antibodies
raised against a peptide from the pol-encoded molecule.
This result supports the prediction that the virus-derived
MMTV RT (similar to the recombinant RT) is covalently
fused at its amino-terminus to the carboxyl-terminal peptide
of the protease and is, hence, a transframe protein.
Results and discussion
The rabbit antisera used in this study to identify the viral
reverse transcriptase molecules were prepared against syn-
thetic peptides with defined sequences derived from MMTV
proteins. The antiprotease serum was prepared against the
peptide with the sequence CDIKVRLMTDSPDDSQDL,
containing the last 17 residues of the carboxyl-terminus of
MMTV protease (with an extra cysteine at the amino-ter-
minus). The anti-RT serum was prepared against a 19-
residues peptide with the sequence CFVIKKKSGK-
WRLLQDLRA, which matches the sequence between
amino acids 66 and 83 in the pol gene-encoded protein (with
an extra cysteine at the amino-terminus). Both antisera were
used in the two sets of experiments described below.
In the experiment described in Fig. 1, the proteins in the
extract of the highly purified C3H strain MMTV virions
were resolved by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE), followed by Western analysis performed
with either the antiprotease or the anti-RT peptides sera. In
parallel, the same electroblotted MMTV proteins were in-
cubated with a control serum. As a positive antigen control,
we have also used the purified recombinant MMTV RT
(version 3 according to Taube et al., 1998), which was
engineered to contain at its amino-terminus the last 27
amino acids from the carboxyl-terminus of the MMTV
protease—in addition to a six histidines tag (to allow fast
purification). This protein is 603 residues long plus the six
histidines plus three other residues (derived from the ex-
pression vector), yielding a total length of 612 amino acids.
As expected, the anti-RT serum recognizes the recombinant
RT with an approximate molecular mass of 66 kDa. The
same antiserum interacts with a viral protein, which is
slightly smaller in size than the recombinant RT (Fig. 1A).
This is probably the mature viral MMTV RT, which has an
apparent molecular mass of about 65 kDa. In addition, a
larger protein can be detected in the virus-derived proteins
(lane 1), which probably represents the Gag-Pro-Pol pre-
cursor polyprotein, pr160 (Dickson and Peters, 1983). No
reaction was apparent when the blotted viral proteins were
incubated with a control rabbit serum (lanes 5 and 6). To
further confirm the specificity of the antigen recognition by
the anti-RT serum, the membrane was incubated with the
antibodies in the presence of an excess of the purified
recombinant MMTV RT. It is obvious that this immunoab-
sorption process has substantially reduced the intensity of
the reaction with the antibodies (that represents the amount
of bound antibodies), suggesting that common antigenic
epitopes are involved (lanes 3 and 4).
2 Abbreviations used: HIV-1, human immunodeficiency virus type-1;
HIV-2, human immunodeficiency virus type-2; MLV, murine leukemia
virus; FIV, feline immunodeficiency virus; BLV, bovine leukemia virus;
HTLV-1, human T cell leukemia virus-1; PERV, porcine endogenous
retrovirus.
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An experiment analogous to that shown in Fig. 1A was
performed with the antiprotease serum (Fig. 1B). As ex-
pected, this serum recognizes the recombinant MMTV RT,
confirming the presence of the protease-derived sequence in
this protein. Interestingly, the same antiserum recognizes an
approximately 65-kDa polypeptide in the virions (lane 1),
which is very likely to be the same viral RT protein recog-
nized by the anti-RT serum. This supports our hypothesis
that sequences derived from the carboxyl-terminus of the
protease are located within the viral RT molecules. The
antiprotease serum also interacts with an approximately
13-kDa polypeptide (which is probably the mature protease)
and also recognizes two larger proteins. The larger one is
presumably the Gag-Pro-Pol pr160 precursor polyprotein
and the other one is likely to be the Gag-Pro pr110 precursor
protein, which can both be found in virions of MMTV
(Dickson and Peters, 1983). The specificity of the immuno-
reaction was confirmed by a competition experiment with
an excess of purified recombinant MMTV protease. No
detectable reaction is apparent, since the sequence of the
recombinant protease has absorbed all antiprotease antibod-
ies (lane 3). This clearly indicates that the antiprotease
serum recognizes in this analysis only the protease-derived
sequences. The conclusion from the experiment described
in Fig. 1 is that there is evidence that the viral RT, similar
to the recombinant protein, contains sequences that are
derived from the carboxyl-terminus of the protease protein.
To further confirm the finding that both the anti-RT and
the antiprotease sera recognize the same viral p65 RT pro-
tein, we have conducted the experiment described in Fig. 2.
In this instance, the viral antigens were first immunopre-
cipitated by either the anti-RT or antiprotease antibodies.
Then, the pellets were resolved by SDS–PAGE that was
followed by a Western analysis, performed with the other
antibody. Thus, the proteins immunoprecipitated with the
anti-RT serum were treated in the Western analysis with the
antiprotease serum and vice versa (immunoprecipitates with
antiprotease serum were tested in the Western analysis with
anti-RT antibodies). The results clearly show that the anti-
protease antibodies recognized the viral p65 protein, immu-
noprecipitated by the anti-RT serum. Moreover, the anti-RT
serum recognized the p65 protein, which had been precip-
itated by the antiprotease antibodies. These findings evi-
dently indicate that both antisera interacted with the same
p65 RT protein.
The data presented herein support our previous hypoth-
esis that viral MMTV RT indeed contains sequences, de-
rived from the carboxyl-terminus of the viral protease, at its
amino terminus. Still, the results presented do not precisely
define the amino-terminus of the viral RT. Our attempts to
isolate the mature viral RT from polyacrylamide gels (on
which the viral proteins have been resolved) and to identify
its amino-terminus, either by microsequencing (using the
Edman degradation) or by mass spectrometry (MS) of the
RT-related peptides (generated by digestion with trypsin—
see Materials and methods), did not lead to conclusive
results. Extremely low amounts of these peptides were gen-
erated and their analysis was difficult and, for that reason,
the sequences obtained were of low significance. This is
probably due to the exceedingly low amount of the mature
RT in MMTV virions. In the future, only a large-scale
purification of this RT from large amounts of purified viri-
ons will probably allow the unambiguous determination of
the precise amino-terminus of this protein. Consequently,
this accurate amino-terminus can be speculated at present
based only on the putative cleavage sequence specificities of
Fig. 1. Western blot analysis of viral and recombinant MMTV RT. Ten
micrograms of purified virions of MMTV C3H (A, lanes 1, 3, and 5; and
B, lanes 1 and 3) or 100 ng of the recombinant MMTV RT (A, lanes 2, 4,
and 6, and B, lanes 2 and 4) was resolved by SDS–polyacrylamide gel
electrophoresis and underwent Western analysis as described under Mate-
rials and methods. (A) The nitrocellulose filters were incubated with either
the antiserum against the MMTV RT-derived peptide (lanes 1 and 2) or the
same antiserum in the presence of 120 ng of purified recombinant MMTV
RT (lanes 3 and 4) or with normal rabbit serum (lanes 5 and 6). (B) The
membranes were incubated with either the antiserum raised against the
protease-derived carboxyl-terminal peptide (lanes 1 and 2) or the same
serum in the presence of 120 ng of the purified recombinant MMTV
protease (lanes 3 and 4).
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the MMTV protease. From these sequence specificities
(Hizi et al., 1989, 1997; Menendez-Arias et al., 1992), we
can still predict the precise amino-terminus of the viral RT
by indicating the two most likely potential cleavages (Fig.
3). However, since the antiprotease serum was prepared
against the last 17 residues of the protein, it seems to us that
alternative cleavage site, marked as No. 1, is more likely
(leaving all the 17 protease-derived residues within the
amino-terminus of the RT). According to this preference, 24
residues from the protease protein (starting with the se-
quence WGRDIMK) constitute the amino-terminus of the
reverse transcriptase protein. Indeed, one of the tryptic pep-
tides identified (unfortunately, only at a marginal signifi-
cance) in the MS of the putative viral RT band might have
started with this sequence (data not shown). Based on the
assumption that both the recombinant and the viral MMTV
Fig. 2. Immunoprecipitation and Western blot analysis of viral and recombinant MMTV RT. Extracts prepared each from 250 g MMTV virions were
immunoprecipitated by either the anti-RT peptide serum (lane 1), the antiprotease peptide serum (lane 3), or normal rabbit serum, followed by incubations
with protein A–Sepharose. The washed immunoprecipitates were loaded onto SDS–polyacrylamide gels along with purified recombinant MMTV protease
(lanes 2, 4, 6, 8) and resolved by electrophoresis. The proteins were electrotransferred from the gel onto nitrocellulose papers. The washed filters were
incubated with either the antiprotease peptide serum (lanes 1, 2, 5, and 6) or the anti-RT peptide serum (lanes 3, 4, 7, and 8). The washed filters were incubated
with goat anti-rabbit IgG antibodies and conjugated to horseradish peroxidase, as described under Materials and methods. The band of approximately 50 kDa
represents the heavy chain of the rabbit IgG antibodies used in the immunoprecipitation step.
Fig. 3. The carboxyl-terminus of MMTV protease and the putative cleavage sites for the formation of amino-terminus of the RT. The last 30 residues of the
protease (numbered backwards from the carboxyl- terminus) are shown along with the two alternative cleavage sites (marked by arrows 1 or 2). The site
marked by an asterisk indicates the amino-terminus engineered previously for the recombinant MMTV RT (see in Taube et al., 1998).
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RT versions share the same carboxyl-terminus, it is likely
that the viral RT is 600 residues long (as opposed to the
recombinant RT that is 612 residues long). The observed
difference of approximately 1 kDa between the molecular
masses of the recombinant and viral RTs (see Figs. 1 and 2)
is in line with our suggestion. Moreover, this conclusion is
also in agreement with our previous proposition that be-
tween 10 and 27 protease-derived carboxyl-terminal se-
quences should be added to the amino-terminus of the RT,
to obtain a fully active recombinant RT (Taube et al., 1998).
The cleavage of the mature RT molecule from the pre-
cursor pr160 polypeptide is catalyzed, as the cleavage of all
other Gag-Pro-Pol proteins, by the MMTV protease. Ac-
cording to the conclusion drawn from the experiments pre-
sented in this study, this cleavage should remove a signifi-
cant portion of the carboxyl-terminus of the protease and,
thus, fuse it to the amino-terminus of the RT. Such a
cleavage will obviously lead to an inactivation by truncation
of the protease molecules, which are derived from the Gag-
Pro-Pol precursor polyprotein. Hence, it is conceivable that
a sequence targeted by such a proteolytic cleavage should
be recognized by the active protease only when it is a part
of the Gag-Pro-Pol molecules and not as part of the Gag-Pro
polyprotein precursor molecules.
The evidence presented in this article strongly supports
the idea that in MMTV, a prototype of type B retroviruses,
there is a dual usage of the protein sequences located at the
carboxyl-terminus of the protease. This segment is an inte-
gral part of both the protease and the RT proteins. In
MMTV, a similar overlapping sequence usage was also
observed in the case of the NC and the p30 (dUTPase)
proteins. Consequently, it is very likely that type B (and
possibly type D) retroviruses have developed a unique de-
pendence on such a mechanism (which is obviously very
efficient in sequence usage, relative to the use of separate
sequences). It will be of interest to study in the future the
mechanisms and the factors that regulate this process in the
context of the life cycle of the viruses.
Materials and methods
Materials
The C3H strain of MMTV grown on the Mm5mt cells
was purified as described (Hizi et al., 1989). The recombi-
nant RT of MMTV was expressed in bacteria and purified as
described in detail previously (Taube et al., 1998). The
MMTV protease was expressed by us in bacteria and puri-
fied (M. Entin-Meer and A. Hizi, unpublished results). The
protease-expressing gene was introduced into a pT5M-
based plasmid, which was engineered to express a six-
histidines tag fused to the amino-terminus of the recombi-
nant protein. The plasmid was used to transform the
BL21(DE3)pLysS strain of Escherichia coli. Expression
and purification of the protease with a six-histidines tag
were performed as described previously in detail for HIV
RTs (Sevilya et al., 2001), except that the purification
procedure involved the use of only a Ni-NTA affinity col-
umn. The two antipeptide rabbit antisera, described in the
text, were generous gifts of Dr. S. Oroszlan from NCI.
These two sera underwent heat inactivation for 30 min at
56°C.
Western blot and immunoprecipitation
Ten micrograms of the purified MMTV virions or 100 ng
purified recombinant MMTV RT were resolved by 9%
SDS–PAGE, followed by electrotransfering of the proteins
to nitrocellulose membranes. The blotted membranes were
incubated overnight in 5% (w/v) milk powder in 30 mM
Tris–HCl, pH 7.5, 125 mM NaCl, 0.1% Tween 20 (TBS-T)
at 4°C (to block nonspecific binding). After blocking, the
membranes were incubated for 1 h at room temperature with
either the anti-RT peptide or the antiprotease peptide sera,
diluted 1:600 in 5% milk powder in TBS-T, followed by
intensive washings with TBS-T buffer. The membranes
were then incubated for an additional hour with a horserad-
ish peroxidase (HRP) conjugated goat anti-rabbit IgG sec-
ondary antibody, purchased from Jackson Labs (diluted
1:40,000 in 5% milk in TBS-T), followed by further inten-
sive washings with TBS-T. The washed membranes were
then subjected for 1 min to the HRP substrate buffer (con-
sisting of 2.5 mM luminol, 400 mM paracumaric acid, 100
mM Tris–HCl, pH 7.5, and 5.4 mM H2O2) and exposed to
an X-ray film for periods of time ranging from 10 s to 1 min.
The films were scanned on a scanner-video densitometer.
For the immunoprecipitation reactions, about 250 g of
purified MMTV virus was disrupted in a buffer containing
50 mM Tris–HCl, pH 8.0, 1 mM EDTA, 1% (v/v) Triton
X-100, and 150 mM NaCl. After extensive mixing, the virus
extract was centrifuged and the supernatant was collected.
Two to four microliters of the serum (either the anti-MMTV
RT peptide or the anti-MMTV protease peptide) were then
added, followed by 3 h incubation with rotation at 4°C. Four
milligrams of protein A–Sepharose beads (Pharmacia) was
then added to the reaction tubes and the whole mixtures
were incubated with rotation at 4°C for an additional hour.
After centrifugation, the pellets were washed three times
with phosphate-buffered saline (PBS) and diluted in equal
volumes of the 2 SDS-PAGE protein sample buffer. The
samples were boiled for 2 min and the supernatants were
collected, loaded on gels, and underwent PAGE and a West-
ern analysis, as described above.
In-gel proteolysis and mass spectrometry analysis
The Coomassie brilliant blue stained protein bands in the
gels were cut with a clean razor blade and the proteins in the
gel were reduced with 10 mM DTT and modified with 100
mM iodoacetamide in 10 mM ammonium bicarbonate. The
gel pieces were treated with 50% acetonitrile in 10 mM
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ammonium bicarbonate to remove the stain from the pro-
teins followed by drying the gel pieces. These dried gel
pieces were rehydrated with 10% acetonitrile in 10 mM
ammonium bicarbonate containing about 0.1 g trypsin per
sample. The gel pieces were incubated overnight at 37°C
and the resulting peptides were recovered with 60% aceto-
nitrile with 0.1% trifluoroacetate. These tryptic peptides
were resolved by reverse-phase chromatography on 0.1 
300-mm fused silica capillaries (J&W, 100 micrometer ID)
home-filled with porous R2 (Perspective). The peptides
were eluted using an 80-min linear gradient of 5 to 95%
acetonitrile with 0.1% acetic acid in water, at flow rate of
about 1 l/min. The liquid from the column was electro-
sprayed into an ion-trap mass spectrometer (LCQ, Finnigan,
San Jose, CA). The MS was performed in the positive ion
mode using repetitively full MS scan. This was followed by
collision-induced dissociation (CID) of the most dominant
ion selected from the first MS scan. The mass spectrometry
data were compared to simulated proteolysis and CID of the
proteins in the NR-NCBI database using the Sequest soft-
ware (J. Eng and J. Yates, University of Washington, sold
by Finnigan, San Jose, CA). The amino-terminal of the
protein was sequenced on Peptide Sequencer 494A (Perkin–
Elmer) according to manufacturer’s instructions.
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